{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:30:23Z","timestamp":1789752623186,"version":"4.0.1"},"reference-count":81,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Public Health Surveill"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The development of new large-scale saliva pooling detection strategies can significantly enhance testing capacity and frequency for asymptomatic individuals, which is crucial for containing SARS-CoV-2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to implement and scale-up a SARS-CoV-2 screening method using pooled saliva samples to control the virus in critical areas and assess its effectiveness in detecting asymptomatic infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Between August 2020 and February 2022, our laboratory received a total of 928,357 samples. Participants collected at least 1 mL of saliva using a self-sampling kit and registered their samples via a smartphone app. All samples were directly processed using AutoMate 2550 for preanalytical steps and then transferred to Microlab STAR, managed with the HAMILTON Pooling software for pooling. The standard pool preset size was 20 samples but was adjusted to 5 when the prevalence exceeded 2% in any group. Real-time polymerase chain reaction (RT-PCR) was conducted using the Allplex SARS-CoV-2 Assay until July 2021, followed by the Allplex SARS-CoV-2 FluA\/FluB\/RSV assay for the remainder of the study period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 928,357 samples received, 887,926 (95.64%) were fully processed into 56,126 pools. Of these pools, 4863 tested positive, detecting 5720 asymptomatic infections. This allowed for a comprehensive analysis of pooling\u2019s impact on RT-PCR sensitivity and false-negative rate (FNR), including data on positive samples per pool (PPP). We defined Ctref as the minimum cycle threshold (Ct) of each data set from a sample or pool and compared these Ctref results from pooled samples with those of the individual tests (\u0394CtP). We then examined their deviation from the expected offset due to dilution [\u0394\u0394CtP = \u0394CtP \u2013 log2]. In this work, the \u0394CtP and \u0394\u0394CtP were 2.23 versus 3.33 and \u20130.89 versus 0.23, respectively, comparing global results with results for pools with 1 positive sample per pool. Therefore, depending on the number of genes used in the test and the size of the pool, we can evaluate the FNR and effective sensitivity (1 \u2013 FNR) of the test configuration. In our scenario, with a maximum of 20 samples per pool and 3 target genes, statistical observations indicated an effective sensitivity exceeding 99%. From an economic perspective, the focus is on pooling efficiency, measured by the effective number of persons that can be tested with 1 test, referred to as persons per test (PPT). In this study, the global PPT was 8.66, reflecting savings of over 20 million euros (US $22 million) based on our reagent prices.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results demonstrate that, as expected, pooling reduces the sensitivity of RT-PCR. However, with the appropriate pool size and the use of multiple target genes, effective sensitivity can remain above 99%. Saliva pooling may be a valuable tool for screening and surveillance in asymptomatic individuals and can aid in controlling SARS-CoV-2 transmission. Further studies are needed to assess the effectiveness of these strategies for SARS-CoV-2 and their application to other microorganisms or biomarkers detected by PCR.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/54503","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T01:10:11Z","timestamp":1721265011000},"page":"e54503","source":"Crossref","is-referenced-by-count":5,"title":["Assessment of the Effective Sensitivity of SARS-CoV-2 Sample Pooling Based on a Large-Scale Screening Experience: Retrospective Analysis"],"prefix":"10.2196","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0397-0868","authenticated-orcid":false,"given":"Jorge J","family":"Cabrera Alvargonzalez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4738-7180","authenticated-orcid":false,"given":"Ana","family":"Larra\u00f1aga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6359-895X","authenticated-orcid":false,"given":"Javier","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1734-1904","authenticated-orcid":false,"given":"Sonia","family":"P\u00e9rez Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6996-3951","authenticated-orcid":false,"given":"Sonia","family":"Rey Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6952-2219","authenticated-orcid":false,"given":"Carlos","family":"Davi\u00f1a Nu\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9424-9653","authenticated-orcid":false,"given":"V\u00edctor","family":"Del Campo P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6850-9080","authenticated-orcid":false,"given":"Carmen","family":"Duran Parrondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9840-6796","authenticated-orcid":false,"given":"Silvia","family":"Suarez Luque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8024-3397","authenticated-orcid":false,"given":"Elena","family":"Gonz\u00e1lez Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4980-7892","authenticated-orcid":false,"given":"Alfredo Jos\u00e9","family":"Silva Tojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2197-3269","authenticated-orcid":false,"given":"Jacobo","family":"Porteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4009-7922","authenticated-orcid":false,"given":"Benito","family":"Regueiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2024,9,24]]},"reference":[{"key":"ref1","unstructured":"World Health OrganizationWHO COVID-19 dashboarddata.who.int2023-08-15https:\/\/data.who.int\/dashboards\/covid19\/cases?n=c"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb6936"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(20)30074-7"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2020.25.4.2000058"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe2009758"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.587374"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0249090"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2015897"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abd5393"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2025631"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe9187"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05446-0"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqaa064"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0240652"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-020-01048-1"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.5445"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa531"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.06.009"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26005"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25971"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.202000250"},{"key":"ref22","unstructured":"National Center for Immunization and Respiratory Diseases (US)Interim guidance for use of pooling procedures in SARS-CoV-2 diagnostic, screening, and surveillance testingCenters for Disease Control and Prevention202007232024-08-15https:\/\/stacks.cdc.gov\/view\/cdc\/90937"},{"key":"ref23","unstructured":"ShurenJeffCoronavirus (COVID-19) update: facilitating diagnostic test availability for asymptomatic testing and sample poolingFood and Drug Administration (FDA)202006162024-08-15https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-facilitating-diagnostic-test-availability-asymptomatic-testing-and"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.1722"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2017.35"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2018.06.009"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/odi.13526"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2016359"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.8876"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.05.001"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2020.115206"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3201\/eid2704.204199"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-1992-2"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/5807370"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1067\/mpr.2001.113778"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2005.063206"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2021.04.005"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02360-20"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00178-8"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02686-20"},{"key":"ref41","unstructured":"U.S. Food and Drug Administration (FDA)Coronavirus (COVID-19) update: FDA authorizes first diagnostic test using at-home collection of saliva specimensFDA202005082023-08-15https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-authorizes-first-diagnostic-test-using-home-collection-saliva"},{"key":"ref42","unstructured":"European Centre for Disease Prevention and Control (ECDC)Considerations for the use of saliva as sample material for COVID-19 testingECDC20212023-08-15https:\/\/tinyurl.com\/4t3spa9c"},{"key":"ref43","unstructured":"U.S. Food and Drug Administration (FDA)Amending certain EUAs for RT-PCR molecular-based diagnostic tests to authorize the detection of nucleic acid from SARSCoV-2 from pooled anterior nasal respiratory specimens for screening when used as part of a serial testing programFDA202104202023-08-15https:\/\/www.fda.gov\/media\/147737\/download"},{"key":"ref44","unstructured":"Fundaci\u00f3n Biom\u00e9dica Galicia SurPooling Instituto de Investigaci\u00f3n Sanitaria Galicia Sur (IISGS)IISGS20202023-08-15https:\/\/pooling.iisgaliciasur.es\/"},{"key":"ref45","unstructured":"Landra SistemasPooling Vigo (Sample Registration)Pooling Vigo20202023-08-15https:\/\/poolingvigo.com\/#\/"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1385\/1-59745-229-7:205"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2105180119"},{"key":"ref48","unstructured":"Centers for Disease Control and Prevention (CDC)COVIDTracer and COVIDTracer AdvancedCDC202101192023-08-15https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/php\/contact-tracing\/COVIDTracerTools.html"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abf2823"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1098\/rsos.210704"},{"key":"ref51","unstructured":"U.S. Food and Drug Administration (FDA)SARS-CoV-2 viral mutations: impact on COVID-19 testsFDA202309282023-08-15https:\/\/www.fda.gov\/medical-devices\/coronavirus-covid-19-and-medical-devices\/sars-cov-2-viral-mutations-impact-covid-19-tests"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.615099"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.5607"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2021.26.10.2100130"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2021.115491"},{"key":"ref56","unstructured":"Centro de Coordinaci\u00f3n de Alertas y Emergencias SanitariasActualizaci\u00f3n de la situaci\u00f3n epidemiol\u00f3gica de las variantes de SARS-CoV-2 en Espa\u00f1aMinisterio de Sanidad202305232023-08-15https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/ccayes\/alertasActual\/nCov\/documentos\/COVID19_Actualizacion_variantes_20230522.pdf"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-34882-6"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.21106\/ijma.571"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30120-1"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2117385"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00592-1"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab643"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00841-7"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02229-22"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsb2104756"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30163-4"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7002e2"},{"key":"ref68","unstructured":"PriyaChidambaramOver 200,000 residents and staff in long-term care facilities have died from COVID-19KFF202202032023-08-15https:\/\/www.kff.org\/policy-watch\/over-200000-residents-and-staff-in-long-term-care-facilities-have-died-from-covid-19\/#:~:text=More%20than%20200%2C000%20long%2Dterm,deaths%20over%20this%20bleak%20milestone"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-018-0055-5"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-10128-9"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1098\/rsif.2021.0155"},{"key":"ref72","unstructured":"Instituto de Salud Carlos IIICentro Nacional de Epidemiolog\u00edaInforme SiVIRA de Vigilancia de gripe, COVID-19 y VRS Espa\u00f1a, temporada 2021-2022Instituto de Salud Carlos III2022092023-08-15https:\/\/tinyurl.com\/yc5aw3aa"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.2196\/44349"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2022.09.006"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1550"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.03.009"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-41904-w"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1126\/science.abm7796"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.22.288220"},{"key":"ref80","unstructured":"World Health Organization (WHO)Prioritizing diseases for research and development in emergency contextsWHO2023-08-15Geneva, SwitzerlandWHOhttps:\/\/www.who.int\/activities\/prioritizing-diseases-for-research-and-development-in-emergency-contexts"},{"key":"ref81","unstructured":"ZenodoLarge-scale saliva pooling as a screening strategy to control transmission raw dataZenodo202304102024-08-15https:\/\/zenodo.org\/record\/7813744#.ZDgP23ZBxD8"}],"container-title":["JMIR Public Health and Surveillance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publichealth.jmir.org\/2024\/1\/e54503","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:41:18Z","timestamp":1782841278000},"score":1,"resource":{"primary":{"URL":"https:\/\/publichealth.jmir.org\/2024\/1\/e54503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,24]]},"references-count":81,"URL":"https:\/\/doi.org\/10.2196\/54503","relation":{"has-preprint":[{"id-type":"doi","id":"10.2196\/preprints.54503","asserted-by":"object"}]},"ISSN":["2369-2960"],"issn-type":[{"value":"2369-2960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,24]]}}}